These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 916488)

  • 1. [Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1977 Aug; 52(8):373-6. PubMed ID: 916488
    [No Abstract]   [Full Text] [Related]  

  • 2. Turning intermittent regimens into daily regimens using blister-packs. An exploration in murine tuberculosis.
    Guy A; Dickinson JM; Mitchison DA
    Tuber Lung Dis; 1993 Oct; 74(5):310-6. PubMed ID: 8260664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

  • 4. [An attempt to work out highly efficient short-course regimens by model experiments in mouse tuberculosis (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1978 May; 53(5):295-8. PubMed ID: 671951
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2381-6. PubMed ID: 4426257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short-term initial chemotherapy with isoniazid, rifampin and ethambutol (streptomycin) in biphasic (3+6) administration, from the intermittent (2/7) beginning. Results after 2 years (cooperative experiment)].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):79-90. PubMed ID: 195328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
    Hoose C
    Prax Pneumol; 1975 Sep; 29(9):517-9. PubMed ID: 1208336
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
    Suzuki T
    Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 13. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of tuberculosis].
    Broquié G
    Soins; 1982 May; 27(9):31-4. PubMed ID: 6920111
    [No Abstract]   [Full Text] [Related]  

  • 19. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
    Regli J; Ziegler WJ
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):49-50. PubMed ID: 4212815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.